브이원바이오 ㅣ V1bio Inc

(주) 브이원바이오 (V1bio Inc)

Welcome ! We are V1bio Inc.

건강하고 가치있는 원헬스 생태계를 만들고, 혁신적인 마이크로바이옴 치료제로 전 세계 환자의 삶을 변화시키 위해 설립된 브이원바이오(V1bio)는 건강한 동물로부터 유용 미생물을 발굴하여 항암 및 면역분야의 혁신적 생균 치료제 (LBP; Live Biotherapeutic Product)를 연구개발하고 있습니다.

브이원바이오는 지속 연구개발과 함께 독자적 연구 플랫폼 고도화로 개발파이프라인을 확보하고, 기술사업화 성공을 통하여, 보다 빠르게 글로벌 마이크로바이옴 치료제 신약개발 전문기업으로 성장하고자 합니다.

Vision

Mission

' Top-tier microbiome biotechnology company '

We are dedicated to pursuing groundbreaking microbiome to discover and develop medicines

Mission

Our mission is to provide the better lives of patients worldwide with revolutionary One Health microbiome and solutions

Value

Mission

Value

Respect for people, Act with intergrity

Communication with open-minded

Continuous challenge for innovation

Pioneer in utilizing revolutionary microbe as medicine

Proprietary platform

One Health microbiome library

Microbiome profiling (AI & BI)

Multi-omics analysis, Translational research

Focus areas

Proprietary platform

Live biotherapeutic product (single strain)

Oncology, Immunology

One Health microbiome

Open collaboration

Proprietary platform

Open collaboration

Collaborative research

In-Iicensing

Out-licensing

Research platform

Research approach based on One Health

One Health is at the intersection of human health, animal health, and environmental health. The structural and functional similarity of the dog microbiome to the human one implies that, as human studies are predictive of results in dogs, dog studies may be predictive of results in humans.

VMPioneer: Valuable Microbiome Pioneer

Our platform drives live biotherapeutic product candidate discovery and development and is the proprietary R&D platform in the microbiome area. We use VMPioneer to interrogate our extensive library of bacterial isolates to identify live biotherapeutic candidates for a targeted disease with a deep understanding of functionality, mechanism and the knowledge translation of research findings.